762K trade after close @ 1.28. Noteworthy.

In reference to the author of the article he also owned IMUC and said that it would outperform the S&P 500. If you aren't familiar with IMUC check her out. Pretty ugly girl right now with a very bleak future. Wonder how many people listened to this guy's BS and bought that turd?

Yeah and analysts had IMUC with a price target of $9. Now look at it. From $2.72 yesterday to $1.28 this am. Sunk like a rock...........or should I say "sunk like an Amphibious Yugo trying to cross the Rhine". All analysts have an agenda and it doesn't include anything beneficial for the retail investor, kind of like those "Amphibious Yugos".

Same here Bidrite. I rarely hold a position longer than a month. After learning more about PP and their potential I've held this stock longer than any I've had for a long time; been in since July. Started to sell my position after the Au trip but felt more comfortable holding this stock than I did watching from the sidelines. I've always felt it is much easier to ride that horse out of the barn than it is to try and catch it.

Whole numbers, 1.40/1.50/1.60/2.00 ect. are a source of resistance. Without sufficient volume the PPS will continue to bounce off this resistance point. After Thanksgiving, providing everything remains static, we should have a few weeks where the volume will be more conducive to breaking this barrier.

Not when the RSI sits at 57.03

The trial isn't back on. The judge allowed for a final amendment. The time frame is 2 months due to the holidays, Jan 22. If at that time the Plaintiff cannot provide anymore compelling evidence than they have presented so far the Judge will dismiss with prejudice. At this point I would not be surprised if the Plaintiff just cut his losses and went away. To file another amendment without additional info to make their case is just throwing money away.

I've not read that before. Thanks for posting.

There are a number of jobs, mainly manager and director positions. I think Biopharm had a list just a few days ago.

This company is fraudulently posting jobs to give retailers the false impression that something big is coming? Seriously? Time to take off the tin foil hat. Put it away and go get some fresh air. Breathe deeply now.

It isn't that their financial health is that bad. I think the future prospects for this company is enormous; a game changer. But for now, their revenue stream cannot justify this pps. Too much speculation and "irrational overexuberance"; cue Greenspan from the 90s; has led to a run up that cannot be justified. One day, maybe.

I've traded this stock back and forth for several months. I got out after it ran to $7. This company has huge potential but in no way can the current price let alone the price of $13+ be justified with their current state of financial health. I wouldn't be surprised to see this dip well below $4. This was way overbought based entirely on speculation. One day maybe, but not now.

Hey Wook, he'd be saying "BUY TO COVER...BUY TO COVER...BUY TO COVER!!!!!!!!!!!

Yeah, that is a very complex question. Though very intriguing. I would love to listen to the Gates' firm interpretation of how this would work, if it could.

You would need an attorney/firm that specializes in M&A and/or securities law to answer that one. From a layman's perspective the law can be very tricky. What seems to be common sense to those outside the legal arena quite often find it is the exact opposite according to the law. I am familiar with the SEC and the unbelievable amount of undecipherable regulations that govern public traded companies. This would require getting {real deep into the woods} for an accurate answer.

Very good point about the funding. Not many have made that connection, at least that I have read. Lenders do not want to assume the risk of lending to a company, public or private, that have an ongoing law suit. Will be interesting how things loosen up once this is dismissed.

How do you get sabotage out of that post. No where was that mentioned. BTW, only if it can be proven would criminal charges be filed. Just because sabotage occurs doesn't mean that automatically criminal proceeding begin. Another attempt at distract and distort?

This would be great but, are these guys ever right?

To say "PP has no credibility with Wall Street" is getting the cart ahead of the horse. Wall Street for the most part has no idea PP even exists. The big boys only begin to pay attention to a stock after it trades above $5. Most large institutions of any repute have an internal rule that they will not buy a security for their portfolio if it trades below $5. Most consider anything below $5 to be a penny stock, which is what PP is. A penny stock, for the time being.

Simply a spike in short interest.

Sounds better that he is taking a conservative approach. I wasn't sure how to interpret some of his remarks. Thanks for the response.

Hey Wook, what are your thoughts on the comments made by your Phd friend? The words "nervous" and "red flag" certainly caught my eye.

Great post. Thank you. Just made my week.

Looks like another example of Big Pharma lobbyists influencing Washington. IMO a shrewd, strategic move designed to steal proprietary information from these micro-caps by utilizing a corrupt legal system. Will be interesting to see how many patents get revoked and reassigned to the hands of large drug makers.

Currently, there is an explosion of small bio-techs coming on line in the oncology field. So much that, the doctors can't even keep up with the new drugs being developed and it looks like Big Pharma had it with these guys pissin' in their sandbox. IMO this does not bode well for Peregrine.

A power play to bring some stubborn small bio-techs to the bargaining table?

Unproven "for now", but not {{untrusted}}. Otherwise the FDA would have never allowed it to advance to PIII.

No one knows for sure but, after spending more time than I care to recall in law school and a nephew as a civil attorney,I do know how attorneys think. I would be amazed if general counsel did not advise the BOD to release only what they are required to. One thing attorneys all do, both civil and criminal, they tell their clients to shut up and let them do the talking. Particularly, when you are as close to a dismissal as Peregrine is. Now, do I know this for sure? Of course not. But, it would be considered malpractice if a civil attorney were to tell his client say what you want when a case was virtually in the bag and his client revealed information that turned the tide of the suit.

As far as the market goes, I agree, it is a dirty game. Illegal activities, stock manipulation, insider trading are the norm as well as the fleecing of the retail investor. If I recall correctly, 90% of retail investors lose money in the market due to not understanding the game.

My timeline for this stock is until the end of the year. I've already held much longer than normal, 2+ months. The only reason why I'm holding this long is that I do believe that the class action may have dried up some communications and the potential for ROI is worth holding a little longer. I'm also aware the BOD has been inconsistent in their messages, however, in their business, events can and do occur that they have no control over. As such, they adjust the best they can. What those events may be is anyone's guess. In regards to the lack of info I believe much of this is due to the class action. I would be shocked if general counsel didn't advise the BOD to release only the info required to fulfill their fiduciary responsibilities. Other than that "play it close to the vest" and say nothing. I think it is a given that the plaintiff's counsel is looking and searching for anything they can find to win this appeal and the defense knows this. I think we will all know what is what by the end of '13.

Thanks SR. IMO I think the BOD is driving a very hard bargain right now. After salvaging PIII approval they acquired another bargaining chip, which imo is reflected in their statement of "going it alone". Basically, sending a shot across the bow of potential suitors that if you want in on this you are going to have to pay. I also think that they are not taking this stance based on blind faith. I believe they know something and that something, in their estimation, allows them to play hardball.

In regards to the potential purchaser/partner and what they are thinking is anyone's guess. A lot of business deals become very complicated when egos get involved. In this business of large corporations, CEOs, PHds, ect there is no shortage of egos and childish behavior behind closed doors.

This is the "Holy Grail" for drug makers. Develop a treatment/drug/vaccine that given in regular intervals for the life of the patient that would keep the cancer in remission. What they would not want is an outright cure; a vaccine that could be administered at an early age, such as the polio vaccine, that is a one time dose. Put it this way, if drug makers had their choice of the two scenarios which one would they select?

Happy to share. I often confer with my wife before taking a position. It really helps to get feed back/guidance on the scientific end of things, even though I'm a former FA. This is my weak area. Actually, some of the posts by the scientific types lose me at times.

Just hoping to offer a positive perspective on a bad day. When PPS starts to fall it is easy to forget why you invested in the first place.

The big boys want retail investors in the mix. When they are selling out the retail investors keeps the price afloat until they are done. Conversely, when the retail investors are bailing out because they have had it, the institutions are establishing new positions.

FWIW Thoughts from a regulatory perspective:

My wife works for a large medical device maker in San Diego as a senior regulatory compliance analyst/medical expert. She spent several years with Abbott as well. Naturally, I talk to her about Peregrine, their pipeline, Bavi mostly, and the issue with Fargo and label switching. Since I'm new to Peregrine, only long for 2 months now, I've been trying to wrap my head around all the twists and turns of the PII debacle and years of investor disappointment. The other day after another drop in PPS I asked her:

"If PII ended in such a mess where dose/label switching occurred why would the FDA allow a PIII"? Wouldn't they require another PII? She said, "For the FDA to allow a PIII after that tells me that they saw something pretty good in the results. I would be very surprised if they allow this to go to PIII with just minimal/average results".

"If Bavi is the "real deal", in your opinion, how important is it for Peregrine to partner, or, would they be better off to go it alone"? She said, " If this drug turns out to be a game changer they will have to partner with some very deep pockets for protection. If they don't "they will kill it", they meaning large drug makers that see their market share threatened. She went on to say "drug makers do not do not want to cure cancer. There is just too much money to be made in treating the disease".

This comes from a very practical, down to earth, non-conspiratorial type of mind.

BTW I asked her to get the opinion of a Director/Attorney she knows at her place of work. This individual is an expert in clinical trials and highly thought of. I'll pass along their thoughts as well.

GLTA

Either someone {really knows something} or is speculating on an upcoming PR.

Check out http://shortvolume.com. This shows the daily short interest. It began to spike after the Au trip and no PR.

The PR never materialized. Many of the shorts covered prior to the Au trip in anticipation of news. If I were short at that time that is exactly what I would have done. However, the PR never came and subsequently provided another opportunity for shorts to re-enter. Though their window may be closing quickly there is enough time to make a few bucks and get out. If you go to shortvolume.com you will see a spike in short activity after last Friday.

You can't win a pissin' contest with a skunk. Just focus on what you can control and move forward.

For anyone who holds a position with this stock there are three things that should provide confidence in your investment. First, the SA author is holding a short position and is desperate to drive the PPS down. He/she sees that this could explode to the upside after 6/19 and is in damage control mode right now. There was nothing note worthy, new or of any significance written in this article. Further, the doctors and so called experts quoted in the article remained suspiciously anonymous. Secondly, institutions have been buying on a regular basis starting on 2/22/13. Finally, there is the insider buying. Some basher belittled the CEO buying 10,000 shares. Obviously this person doesn't understand that CEOs, Directors, VPs and other high ranking management personnel didn't get to that point in their career by being stupid and making irrational decisions. There are no guarantees in investing but when I see institutions and insiders buying I just follow the money. GTLA

This company will be lucky to see $200 in revenue for the entire operation. This is a dead man walking. Single digits coming soon.

What happens when it goes below .10? And it will.